Tumor Necrosis Factor-alpha Antibodies in Fistulizing Crohn's Disease: An Updated Systematic Review and Meta-analysis

Medical treatment for fistulizing Crohn's disease (FCD) is changing rapidly over the time by the introduction of novel therapeutic medicines, while no global consensus is available. This study aims to accomplish a systematic review and meta-analysis on the efficacy of tumor necrosis factor-alph...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaboli, Pardis, Abdollahi, Mohammad, Mozaffari, Shilan, Nikfar, Shekoufeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632933/
https://www.ncbi.nlm.nih.gov/pubmed/29026838
http://dx.doi.org/10.4103/jrpp.JRPP_17_46

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632933/
https://www.ncbi.nlm.nih.gov/pubmed/29026838
http://dx.doi.org/10.4103/jrpp.JRPP_17_46

Ejemplares similares